Chronic Hepatitis Delta Virus Infection

Infectious Diseases
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GS
Gilead SciencesFOSTER CITY, CA
1 program
BulevirtideN/APeptide1 trial
Active Trials
NCT06780579Available

Clinical Trials (1)

NCT06780579Gilead SciencesBulevirtide

Expanded Access for Bulevirtide

N/AAvailable

Related Jobs in Infectious Diseases

Director, Program Management

Metaphore Biotechnologies
Somerville, MA USA
9h ago
$179K - $237K/yr

Consultor Técnico Vacinas Adulto (Brasília/DF)

GSK
BRA - Distrito Federal - Brasília
22h ago

Production Supervisor/First Line Leader

GSK
USA - North Carolina - Zebulon
22h ago

Community Engagement Account Manager - New Haven

GSK
USA - Connecticut - New Haven
22h ago

Scientist, Protein Purification

GSK
USA - Massachusetts - Cambridge
22h ago
$90K - $150K/yr

Scientist, Protein Biochemistry

GSK
USA - Massachusetts - Cambridge
22h ago
$90K - $150K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

HIV Infections(449)COVID-19(223)Hepatitis C(191)Influenza(173)HIV(138)HIV-1-infection(115)Hepatitis C, Chronic(94)Chronic Hepatitis B(93)Chronic Hepatitis C(91)Covid19(79)